CIK 0001042418
- Non-accelerated filer
- Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 541641133
- Phone
- +1 813-766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- 4/A Open-market sale Controller sold 6,617 shares at $7.50 ($49,628)
- 4 Open-market sale Chairman sold 17,700 shares at $6.80 ($120,360)
- 4 Open-market sale Controller sold 6,617 shares at $7.50 ($49,628)
- 4 Open-market sale President and CEO sold 32,450 shares at $6.87 ($222,932)
- 4 Open-market sale Senior Vice Pres/Secretary sold 32,450 shares at $6.87 ($222,932)
- 4 Open-market sale Chairman sold 14,300 shares at $7.35 ($105,105)
- 4 Open-market sale Director sold 2,442 shares at $10.24 ($25,006)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale President and CEO sold 3,000 shares at an average $3.17 ($9,507)
- 4/A Open-market sale Secretary and Senior Vice Pres sold 3,000 shares at an average $3.24 ($9,729)
- 4/A Open-market sale President and CEO sold 3,000 shares at an average $3.17 ($9,507)
- 4 Open-market sale Former Director sold 10,000 shares at an average $2.03 ($20,250)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 11 · 219 filings